| Fibroblasts in the Infarcted, Remodeling, and Failing Heart |
36 |
| The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE(-/-) and LDLr-/- Mice by a Mechanism That Includes Inflammatory Pathways |
33 |
| CCR2(+) Monocyte-Derived Infiltrating Macrophages Are Required for Adverse Cardiac Remodeling During Pressure Overload |
32 |
| Ticagrelor Reduces Thromboinflammatory Markers in Patients With Pneumonia |
28 |
| First-in-Man Study of a Cardiac Extracellular Matrix Hydrogel in Early and Late Myocardial Infarction Patients |
25 |
| Emerging Applications of Virtual Reality in Cardiovascular Medicine |
24 |
| Elamipretide Improves Mitochondrial Function in the Failing Human Heart |
23 |
| Cardiac Microvascular Endothelial Enhancement of Cardiomyocyte Function Is Impaired by Inflammation and Restored by Empagliflozin |
22 |
| Radiation-Induced Endothelial Vascular Injury A Review of Possible Mechanisms |
20 |
| 3D Printing is a Transformative Technology in Congenital Heart Disease |
17 |
| Role of Endothelium in Doxorubicin-Induced Cardiomyopathy |
17 |
| SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in the Diabetic and Nondiabetic Heart |
17 |
| In Vivo Reactive Oxygen Species Detection With a Novel Positron Emission Tomography Tracer, F-18-DHMT, Allows for Early Detection of Anthracycline-Induced Cardiotoxicity in Rodents |
17 |
| Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes |
16 |
| Pharmacogenetic Labeling of FDA-Approved Drugs A Regulatory Retrospective |
15 |
| Empagliflozin Improves Diastolic Function in a Nondiabetic Rodent Model of Heart Failure With Preserved Ejection Fraction |
15 |
| Atrial Myopathy |
15 |
| Red Blood Cells in Type 2 Diabetes Impair Cardiac Post-Ischemic Recovery Through an Arginase-Dependent Modulation of Nitric Oxide Synthase and Reactive Oxygen Species |
14 |
| Characterization of the Myocardial Inflammatory Response in Acute Stress-Induced (Takotsubo) Cardiomyopathy |
13 |
| Rapid Endothelialization of Off-the-Shelf Small Diameter Silk Vascular Grafts |
13 |
| Neutrophil Subsets, Platelets, and Vascular Disease in Psoriasis |
13 |
| JAK2(V617F)-Mediated Clonal Hematopoiesis Accelerates Pathological Remodeling in Murine Heart Failure |
13 |
| Fatty Acids Prevent Hypoxia-Inducible Factor-1 alpha Signaling Through Decreased Succinate in Diabetes |
12 |
| Connective Tissue Growth Factor Inhibition Enhances Cardiac Repair and Limits Fibrosis After Myocardial Infarction |
12 |
| Epigenetics in Cardiac Fibrosis Emphasis on Inflammation and Fibroblast Activation |
12 |
| Novel Multiomics Profiling of Human Carotid Atherosclerotic Plaques and Plasma Reveals Biliverdin Reductase B as a Marker of Intraplaque Hemorrhage |
11 |
| Angiopoietin-Like 3 From Discovery to Therapeutic Gene Editing |
11 |
| Targeting Calpain for Heart Failure Therapy Implications From Multiple Murine Models |
10 |
| Novel Adult-Onset Systolic Cardiomyopathy Due to MYH7 E848G Mutation in Patient-Derived Induced Pluripotent Stem Cells |
10 |
| Increased Afterload Augments Sunitinib-Induced Cardiotoxicity in an Engineered Cardiac Microtissue Model |
10 |
| Kruppel-Like Factors Crippling and Uncrippling Metabolic Pathways |
10 |
| A Novel Biological Strategy for Myocardial Protection by Intracoronary Delivery of Mitochondria: Safety and Efficacy |
10 |
| Discovery of a Small Molecule to Increase Cardiomyocytes and Protect the Heart After Ischemic Injury |
10 |
| Cardiovascular Precision Medicine in the Genomics Era |
9 |
| Hypermethylation of the Micro-RNA 145 Promoter Is the Key Regulator for NLRP3 Inflammasome-Induced Activation and Plaque Formation |
9 |
| Electrical Vagal Nerve Stimulation Ameliorates Pulmonary Vascular Remodeling and Improves Survival in Rats With Severe Pulmonary Arterial Hypertension |
9 |
| Limitations of Animal Studies for Predicting Toxicity in Clinical Trials Is it Time to Rethink Our Current Approach? |
9 |
| Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension |
9 |
| Epigenetics in Cardiac Hypertrophy and Heart Failure |
9 |
| Neuromodulation for the Treatment of Heart Rhythm Disorders |
9 |
| Short-Term Hemodynamic Effects of Apelin in Patients With Pulmonary Arterial Hypertension |
8 |
| Nitrosative Stress as a Modulator of Inflammatory Change in a Model of Takotsubo Syndrome |
8 |
| Platelet Transcriptome Profiling in HIV and ATP-Binding Cassette Subfamily C Member 4 (ABCC4) as a Mediator of Platelet Activity |
8 |
| Extracellular Matrix From Hypertrophic Myocardium Provokes Impaired Twitch Dynamics in Healthy Cardiomyocytes |
8 |
| Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis |
8 |
| Phase II Trials in Drug Development and Adaptive Trial Design |
8 |
| Therapeutic Genome Editing in Cardiovascular Diseases |
7 |
| Cardiomyocyte SMAD4-Dependent TGF-beta Signaling is Essential to Maintain Adult Heart Homeostasis |
7 |
| Malonyl CoA Decarboxylase Inhibition Improves Cardiac Function Post-Myocardial Infarction |
7 |
| Acute Kidney Injury Induces Remote Cardiac Damage and Dysfunction Through the Galectin-3 Pathway |
7 |
